Akumin announces its adoption of Lunit's AI-driven breast cancer detection software.

Akumin Inc. has chosen Lunit's artificial intelligence-powered Insight DBT breast diagnostic software to enhance its breast imaging offerings.

, and Administrator

2025 September 12 . 12:33 AM

1 min read

"Akumin has incorporated Lunit's artificial intelligence-driven breast imaging software"

Akumin announces its adoption of Lunit's AI-driven breast cancer detection software.

In a significant move to enhance its breast imaging services, Akumin, a leading provider of outsourced radiology services, has selected Lunit's Insight DBT breast screening software. This AI-based tool, designed for analyzing digital breast tomosynthesis (DBT) images, is set to improve the detection of early-stage cancers and reduce false positives in breast imaging.

Lunit's Insight DBT, which has been cleared by the U.S. Food and Drug Administration (FDA) for 3D image use, is a valuable addition to Akumin's strategy. The integration of this advanced technology will expand patient access to precision diagnostics across Akumin's network of over 1,000 healthcare providers and physician groups across the U.S.

Akumin operates more than 150 fixed sites and mobile imaging units, and the exact locations where Lunit's Insight DBT software will be used for breast imaging services this year have not been publicly specified. However, the adoption of this technology is an important step in Akumin's plans to integrate advanced technologies into its operations.

Lunit's Insight DBT has demonstrated its ability to improve the detection of early-stage cancers, reducing the number of false positives in breast imaging. This makes it an ideal tool for Akumin as they strive to provide accurate, reliable, and efficient breast imaging services to their patients.

By integrating Lunit's Insight DBT, Akumin aims to enhance its breast imaging services, providing a more comprehensive and precise approach to breast cancer detection. This move further solidifies Akumin's commitment to delivering high-quality, patient-centric care.